| Literature DB >> 33833976 |
Jong Woo Won1, Seong Kwan Jung2, In Ah Jung2, Yoon Lee1.
Abstract
PURPOSE: This study aimed to investigate the seasonal changes in vitamin D levels in a healthy pediatric population living in mid-latitude East Asian urban areas.Entities:
Keywords: Calcitriol; Child; Infant; Seasons; Vitamin D; Vitamin D deficiency
Year: 2021 PMID: 33833976 PMCID: PMC8007836 DOI: 10.5223/pghn.2021.24.2.207
Source DB: PubMed Journal: Pediatr Gastroenterol Hepatol Nutr ISSN: 2234-8840
Median serum 25(OH)D (ng/mL) levels of each month
| Month of year | All | SS | NSS | |||
|---|---|---|---|---|---|---|
| January | 40 | 24.0±15.1 | 8 | 27.6±18.9 | 32 | 23.2±14.2 |
| February | 41 | 21.4±9.6 | 9 | 30.4±13.1 | 32 | 18.9±6.6 |
| March | 39 | 21.4±16.3 | 13 | 30.0±23.9 | 26 | 17.2±8.6 |
| April | 41 | 23.2±11.3 | 17 | 28.3±13.6 | 24 | 19.7±7.9 |
| May | 61 | 22.0±8.9 | 20 | 24.3±9.7 | 41 | 20.9±8.4 |
| June | 40 | 30.7±11.7 | 22 | 34.8±13.3 | 18 | 25.8±6.8 |
| July | 31 | 29.5±8.4 | 18 | 30.8±9.8 | 13 | 27.7±5.8 |
| August | 36 | 32.2±8.9 | 25 | 32.7±9.0 | 11 | 30.8±9.0 |
| September | 33 | 32.5±9.8 | 24 | 33.2±11.0 | 9 | 30.5±5.8 |
| October | 40 | 24.2±9.4 | 6 | 31.8±10.6 | 34 | 22.8±8.7 |
| November | 39 | 24.4±11.7 | 7 | 30.6±16.6 | 32 | 23.0±10.2 |
| December | 40 | 22.4±10.5 | 3 | 23.0±9.6 | 37 | 22.4±10.7 |
| Whole year | 481 | 25.3±11.8 | 172 | 30.6±13.2 | 309 | 22.3±9.7 |
Values are presented as number only or mean±standard deviation.
25(OH)D: 25-hydroxyvitamin D, SS: supplemented subjects, NSS: non-supplemented subjects.
Fig. 1Box plot (box from Q1 to Q3) showing 25(OH)D levels (ng/mL) among all monthly participants (n=481), supplemented subjects (n=172), and non-supplemented subjects (n=309). Tails show minimum and maximum values, while the center line, –, in a box indicates the median.
25(OH)D: 25-hydroxyvitamin D.
Fig. 2(A) Subjects not receiving vitamin D supplementation showed uneven monthly distribution with statistical significance (p=0.002). (B) Vitamin D supplemented subjects also showed uneven distribution (p=0.021), but they made up a larger fraction of the adequate subgroups and a smaller fraction of the deficient subgroups.
Serum 25(OH)D level range distribution according to the supplementation status
| Serum 25(OH)D level | January | February | March | April | May | June | July | August | September | October | November | December | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SS | NSS | SS | NSS | SS | NSS | SS | NSS | SS | NSS | SS | NSS | SS | NSS | SS | NSS | SS | NSS | SS | NSS | SS | NSS | SS | NSS | |
| Adequate (≥30 ng/mL) | 2 (25.0) | 7 (21.9) | 5 (55.6) | 1 (3.1) | 2 (15.4) | 1 (3.8) | 7 (41.2) | 2 (8.3) | 5 (25.0) | 5 (12.2) | 14 (63.6) | 6 (33.3) | 10 (55.6) | 4 (30.8) | 14 (56.0) | 5 (45.5) | 12 (50.0) | 5 (55.6) | 3 (50.0) | 5 (14.7) | 4 (57.1) | 8 (25.0) | 1 (33.3) | 8 (21.6) |
| Insufficient (20–29 ng/mL) | 2 (25.0) | 10 (31.3) | 3 (33.3) | 14 (43.8) | 8 (61.5) | 8 (30.8) | 5 (29.4) | 11 (45.8) | 8 (40.0) | 17 (41.5) | 6 (27.3) | 8 (44.4) | 6 (33.3) | 8 (61.5) | 9 (36.0) | 4 (36.4) | 10 (41.7) | 4 (44.4) | 2 (33.3) | 18 (52.9) | 1 (14.3) | 12 (37.5) | 1 (33.3) | 15 (40.5) |
| Deficient (<20 ng/mL) | 4 (50.0) | 15 (46.9) | 1 (11.1) | 17 (53.1) | 3 (23.1) | 17 (65.4) | 5 (29.4) | 11 (45.8) | 7 (35.0) | 19 (46.3) | 2 (9.1) | 4 (22.2) | 2 (11.1) | 1 (7.7) | 2 (8.0) | 2 (18.2) | 2 (8.3) | 0 (0.0) | 1 (16.7) | 11 (32.4) | 2 (28.6) | 12 (37.5) | 1 (33.3) | 14 (37.8) |
| 1.000 | 0.001† | 0.032† | 0.058 | 0.444 | 0.176 | 0.294 | 0.675 | 1.000 | 0.211 | 0.248 | 1.000 | |||||||||||||
Values are presented as number (%).
25(OH)D: 25-hydroxyvitamin D, SS, supplemented subject; NSS, non-supplemented subject.
*Cross-analyses (Fisher's exact test) between the supplementation status and the vitamin D serum level range subgroups were performed separately for each month.
†The fraction of the adequate subgroup is larger than that of the deficient subgroup, with the latter group having a lesser percentage of supplemented subjects than non-supplemented subjects in February and March.
Vitamin D serum level: number of samples and the subgroup percentages are shown in separately divided cells for the treated/untreated population.
Fig. 3Mean serum 25(OH)D (ng/mL) levels among all monthly participants (n=481), supplemented subjects (n=172), and non-supplemented subjects (n=309) are shown.
25(OH)D: 25-hydroxyvitamin D.
Median serum 25(OH)D levels (ng/mL) of different age groups
| Age group | All | SS | NSS | |||
|---|---|---|---|---|---|---|
| 0 yr | 113 | 25.1 (16.6) | 36 | 27.3 (13.0) | 77 | 23.1 (20.6) |
| 1 yr | 151 | 26.2 (14.1) | 58 | 29.1 (13.3) | 93 | 23 (11.4) |
| 2 yr | 63 | 22.8 (15.4) | 13 | 35.2 (13.3) | 50 | 21.3 (11.2) |
| 3 yr | 65 | 22.8 (12.5) | 21 | 29.1 (11.1) | 44 | 20.1 (9.8) |
| 4 yr | 36 | 23.1 (11.8) | 13 | 32.1 (10.5) | 23 | 19.2 (9.2) |
| 5 yr | 24 | 24.6 (13.3) | 8 | 35.7 (34.1) | 16 | 20.1 (8.2) |
| 6–10 yr | 32 | 20.8 (12.2) | 9 | 24.9 (8.5) | 23 | 17.8 (10.9) |
Values are presented as number only or median (interquartile range).
25(OH)D: 25-hydroxyvitamin D, SS: supplemented subjects, NSS: non-supplemented subject.